Traumatic and hypoxic brain injury (Cerebral Palsy) is a devastating medical condition with high socioeconomic impact as it affects more than 10 million people worldwide annually. Prolonged hospital stay is associated with mortality and disability. Although life expectancy in cerebral palsy has improved continuously for decades, especially in developing countries, an effective drug therapy for brain injury remains a clinical need.